Skip to main content

Featured Articles

Technology, Perspectives
Infant With Rare Condition Becomes First to Successfully Receive Treatment With Personalized Gene Therapy
Read More
FDA Approvals, Pain
FDA Approves First-in-Class Option for Acute Pain
Read More
FDA Approvals, Mental Health
FDA OKs Subcutaneous Apomorphine Infusion for Parkinson’s Treatment
Read More
In-Depth Treatment Profile, FDA Approvals, Bispecific Antibodies
Epkinly Receives Accelerated Approval for Treatment of Follicular Lymphoma After ≥2 Lines of Systemic Therapy
Rohan Vashi, PharmD, MSc
Read More
In-Depth Treatment Profile, A Payer Perspective, FDA Approvals, Bispecific Antibodies
Bispecific Antibody Columvi Offering Option in Diffuse Large B-cell Lymphoma Treatment
Rohan Vashi, PharmD, MSc
Read More
In-Depth Treatment Profile, Multiple Myeloma, Oncology, Bispecific Antibodies
Ongoing Analyses and Recent Data for Talvey in Multiple Myeloma
Rohan Vashi, PharmD, MSc
Read More
In-Depth Treatment Profile
Imdelltra Approved for Treatment of Extensive-Stage Small Cell Lung Cancer on or Following Disease Progression While on Platinum-Based Chemotherapies
Rohan Vashi, PharmD, MSc
Read More

Featured FDA Approvals

FDA Approvals
FDA Approves Datopotamab Deruxtecan-dlnk for Triple-Negative Breast Cancer
Read More
FDA Approvals
FDA Approves Durvalumab in Combination With Bacillus Calmette-Guérin for High-Risk Non–Muscle Invasive Bladder Cancer
Read More
FDA Approvals
FDA Grants Accelerated Approval to Zongertinib for HER2-Mutated NSCLC
Read More
FDA Approvals
FDA Grants Approval to Encorafenib for BRAF V600E–Mutated Metastatic Colorectal Cancer
Read More
FDA Approvals
FDA Approves Teclistamab Combination Therapy for Relapsed or Refractory Multiple Myeloma
Read More
FDA Approvals
FDA Approves Darzalex Faspro-VRd Combination for Newly Diagnosed Multiple Myeloma Patients Ineligible for Transplant
Read More